Inso Bio (formerly Tico Bio) is an early-stage biotech startup from Cornell University developing platform technologies for biological sample processing. We are using our patented microfluidic technology to transform the landscape of cellular sample processing, and we are exploring applications in long-read DNA sequencing, multi-omic analysis, and pathogen isolation.
Location: United States, New York, Ithaca
Employees: 1-10
Total raised: $3.21M
Investors 2
| Date | Name | Website |
| 08.07.2022 | Creative D... | creativede... |
| 30.08.2022 | Kevin M. M... | mcgovernce... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 18.04.2022 | Grant | $955K | - |
| 30.03.2022 | Pre-Seed | $2.2M | - |
| 27.05.2021 | Grant | $50K | - |
Mentions in press and media 1
| Date | Title | Description |
| 01.10.2021 | Here’s all 10 companies from IndieBio’s latest New York cohort | Most big accelerators tend to dedicate some of their resources to dauntingly hard science problems and the companies taking them on… but for SOSV’s IndieBio, it’s the primary focus. Last time we checked in with IndieBio, their companies wer... |